eMedicine.com Inc.

eMedicine. com Inc. is an online platform dedicated to providing healthcare professionals with a wealth of medical information, including clinical guidelines and educational resources to enhance patient care. Founded in 1996 and headquartered in New York, US, eMedicine.

com Inc. serves as a vital resource for healthcare professionals. In January 2006, WebMD Health Corp. acquired eMedicine.

com Inc. for USD 25. 5 mn, marking a significant pivot in the company's operational strategy. The company has been involved in 5 total deals since its establishment.

eMedicine. com Inc. offers an extensive online resource tailored for healthcare professionals, granting access to clinical guidelines, disease overviews, drug databases, and continuing medical education (CME) courses. The platform aids physicians, nurses, and other healthcare practitioners in staying updated with the latest medical research and treatment recommendations, with a focus on enhancing clinical decision-making.

Its resources are utilized globally, particularly in North America, Europe, and parts of Asia, supporting a diverse range of medical specialties. eMedicine. com Inc. primarily generates revenue through medical advertising and sponsorships, collaborating with pharmaceutical companies and healthcare organizations to promote their products and services.

The revenue model includes advertising placements on the platform and subscription-based access to specialized content and services. This model effectively supports the extensive array of clinical resources and educational materials provided to healthcare professionals. Following the acquisition by WebMD Health Corp. in January 2006, eMedicine.

com Inc. is expected to leverage its new backing to innovate and expand its offerings. Upcoming product launches are anticipated, aimed at enhancing the platform's resources for healthcare professionals. Additionally, plans are in place to broaden its reach into new markets, although specific regions have not been disclosed.

The recent acquisition funding of USD 25. 5 mn will be utilized to support these initiatives, emphasizing the company's commitment to delivering comprehensive medical resources.